Medigus’s Revoltz Completes Initial EV Production

Medigus Ltd. (MDGS) has released an update.

Medigus Ltd., through its subsidiary-owned EV joint venture Revoltz, has completed the initial production of 50 PORTO micro-mobility electric vehicles, primed for delivery under a $2.7 million distribution agreement targeting 150 vehicle sales in the first year. The deal, which encompasses the Israeli last-mile delivery market, includes provisions for maintenance and service, reinforcing the PORTO’s design for urban efficiency and stability. Medigus continues to innovate, leveraging its diverse portfolio in medical solutions, digital commerce, and electric vehicles.

For further insights into MDGS stock, check out TipRanks’ Stock Analysis page.